RMMS Notches Additional IPR Victories Related To Aflibercept Dosing Patents BiologicsPTAB January 19, 2024 Read More
RMMS Secures Favorable Resolution in BPCIA Litigation Involving FULPHILA® (pegfilgrastim-jmdb) Biologics November 1, 2019 Read More
RMMS Secures Favorable Claim Construction Ruling in NEULASTA® (pegfilgrastim) BPCIA Litigation Biologics November 20, 2018 Read More
RMMS Scores Win in Europe Relating to Shire’s Factor VIII ADVATE Franchise Biologics May 16, 2017 Read More